Phibro Animal Health Corp (FRA:PB8)
€ 23.8 1.8 (8.18%) Market Cap: 952.18 Mil Enterprise Value: 1.35 Bil PE Ratio: 59.42 PB Ratio: 4.00 GF Score: 72/100

Phibro Animal Health Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 08:40PM GMT
Release Date Price: €25.32 (-0.08%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

I guess, we're going to start off the next session. Thank you for joining us. My name is Mike Ryskin. I'm on the life science tools and diagnostics team here at Bank of America Merrill Lynch, and I also have the privilege of covering the animal health space. And that's where our next presenters fall in. With us, we have Richard Johnson, CFO; and Jack Bendheim, Chairman and CEO of Phibro Animal Health Corp. Thank you for joining us gentlemen. Appreciate you making the trip out here.

Questions & Answers

Michael Leonidovich Ryskin;Jack Clifford Bendheim
BofA Merrill Lynch, Research Division - Associate

I guess, just to start off, to get the ball rolling, reported your most recent quarter a few weeks ago, there were some -- a lot of moving pieces in the quarter, some positive, some negative. If you could sort of talk through high level, just a few minutes, what were the biggest pieces in terms of dairy, African Swine Fever, the Feed Additive business.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot